Ticker Scorecard - TXG Basics Company: 10x Genomics, Inc. IPO Date: September 12, 2019 Sector: Healthcare Industry: Health Information Services Market Cap: $1.33B Activated in VL: True Average Daily Range Avg Daily Range: $1.99 | 2.74% Avg Daily Range (30 D): $0.43 | 3.07% Avg Daily Range (90 D): $0.42 | 2.86% Institutional Daily Volume Avg Daily Volume: .97M Avg Daily Volume (30 D): 2.34M Avg Daily Volume (90 D): 1.96M Trade Size Avg Trade Size (Sh.): 60 Avg Trade Size (Sh.) (30 D): 80 Avg Trade Size (Sh.) (90 D): 78 Institutional Trades Total Inst.Trades: 4,173 Avg Inst. Trade: $3.88M Avg Inst. Trade (30 D): $1.8M Avg Inst. Trade (90 D): $2.52M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $7.23M Avg Closing Trade (30 D): $2.97M Avg Closing Trade (90 D): $3.34M Avg Closing Volume: 114.51K     News Jan 30, 2025 @ 8:30 AM [Latest] Global Single Cell Multiomics Market Size... Source: Custom Market Insights Jan 24, 2025 @ 9:45 AM Spatial Proteomics Market Report and Competitive L... Source: Researchandmarkets.Com Jan 20, 2025 @ 12:00 PM RNA Transcriptome Profiling Tests Market Expands a... Source: Fact.Mr Dec 24, 2024 @ 12:30 PM Cathie Wood Goes Bargain Hunting: 3 Stocks She Jus... Source: Rick Munarriz Aug 8, 2024 @ 9:45 PM 10x Genomics (TXG) Reports Q2 Loss, Tops Revenue E... Source: N/A Financials   TTM Q4 2024 FY 2024 Basic EPS $-1.52 $-.41 $-1.52 Diluted EPS $-1.52 $-.41 $-1.52 Revenue $ 610.79M $ 165.02M $ 610.79M Gross Profit $ 414.48M $ 110.96M $ 414.48M Net Income / Loss $ -182.63M $ -49.03M $ -182.63M Operating Income / Loss $ -194.56M $ -49.84M $ -194.56M Cost of Revenue $ 196.3M $ 54.07M $ 196.3M Net Cash Flow $ -15.22M $ -54.09M $ -15.22M PE Ratio